436 related articles for article (PubMed ID: 6223422)
21. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
22. Incompatibility for or pre-immunization against M1s determinants decreases lethal graft-versus-host reaction developed across non-H-2 and/or H-2 barriers.
Halle-Pannenko O; Festenstein H
J Immunogenet; 1981 Dec; 8(6):443-53. PubMed ID: 6174641
[TBL] [Abstract][Full Text] [Related]
23. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
Pals ST; Radaszkiewicz T; Gleichmann E
J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
[TBL] [Abstract][Full Text] [Related]
24. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
Kubota E; Ishikawa H; Saito K
J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
[TBL] [Abstract][Full Text] [Related]
25. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
Holda JH; Maier T; Claman HN
J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767
[TBL] [Abstract][Full Text] [Related]
26. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
Krzystyniak K; Panaye G; Descotes J; Revillard JP
Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
[TBL] [Abstract][Full Text] [Related]
27. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
[TBL] [Abstract][Full Text] [Related]
28. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
Ishikawa H; Kubota E; Suzuki H; Saito K
J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
[TBL] [Abstract][Full Text] [Related]
29. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
Hakim FT; Shearer GM
J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
[TBL] [Abstract][Full Text] [Related]
30. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
31. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
Ishikawa H; Saito K; Kubota E
J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
[TBL] [Abstract][Full Text] [Related]
32. [The influence of subclinical level of graft versus host reaction on reconstitution of host lymphoid tissues].
Hirano M
Hokkaido Igaku Zasshi; 1994 May; 69(3):453-65. PubMed ID: 7927174
[TBL] [Abstract][Full Text] [Related]
33. Sex-dependent effects of non-H-2 loci on lethal GVH reaction induced across an H-2 barrier.
Halle-Pannenko O; Mary JY; Motta R
Immunogenetics; 1986; 24(4):217-24. PubMed ID: 3781569
[TBL] [Abstract][Full Text] [Related]
34. Evidence for two distinct mechanisms in acute fatal graft-versus-host reaction across minor histocompatibility barriers.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1987 May; 15(4):365-72. PubMed ID: 3494625
[TBL] [Abstract][Full Text] [Related]
35. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
Rozendaal L; Pals ST; Melief CJ; Gleichmann E
Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
[TBL] [Abstract][Full Text] [Related]
36. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
37. Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells.
Halle-Pannenko O; Pritchard LL; Motta R; Mathé G
Biomedicine; 1978 Nov; 29(7):253-5. PubMed ID: 34444
[TBL] [Abstract][Full Text] [Related]
38. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
39. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
Kosmatopoulos K; Algara DS; Orbach-Arbouys S
J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
[TBL] [Abstract][Full Text] [Related]
40. Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes.
Rozendaal L; Pals ST; Schilham M; Melief CJ; Gleichmann E
Eur J Immunol; 1989 Sep; 19(9):1669-75. PubMed ID: 2792183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
